Skip to content
10-Q

Quarterly Report

Nuo Therapeutics, Inc. AURX

0001437749-25-032437

← back to feed
Filed
Oct 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 29, 2025 48.08M sh
Capex Q3 2025 · Sep 30, 2025 $231.55K
Capex Q3 2025 · Sep 30, 2024 $154.96K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$442.33K
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$1.74M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $514.8K
Cash And Equivalents Q3 2025 · Dec 31, 2024 $283.71K
Stockholders Equity Q3 2025 · Sep 30, 2025 −$419.61K
Stockholders Equity Q3 2025 · Jun 30, 2025 −$824.56K
Stockholders Equity Q3 2025 · Mar 31, 2025 −$213.07K
Stockholders Equity Q3 2025 · Dec 31, 2024 $513.71K
Stockholders Equity Q3 2025 · Sep 30, 2024 $890.39K
Stockholders Equity Q3 2025 · Jun 30, 2024 $598.51K
Stockholders Equity Q3 2025 · Mar 31, 2024 $333.45K
Stockholders Equity Q3 2025 · Dec 31, 2023 $1.04M
Current Liabilities Q3 2025 · Sep 30, 2025 $1.26M
Current Liabilities Q3 2025 · Dec 31, 2024 $578.45K
Total Liabilities Q3 2025 · Sep 30, 2025 $2.35M
Total Liabilities Q3 2025 · Dec 31, 2024 $675.8K
Current Assets Q3 2025 · Sep 30, 2025 $1.46M
Current Assets Q3 2025 · Dec 31, 2024 $841.55K
Total Assets Q3 2025 · Sep 30, 2025 $1.93M
Total Assets Q3 2025 · Dec 31, 2024 $1.19M
Eps Basic Q3 2025 · Sep 30, 2025 −$0.01
Eps Basic Q3 2025 · Sep 30, 2025 −$0.04
Eps Basic Q3 2025 · Sep 30, 2024 −$0.01
Eps Basic Q3 2025 · Sep 30, 2024 −$0.04
Sga Expense Q3 2025 · Sep 30, 2025 $1.17M
Sga Expense Q3 2025 · Sep 30, 2025 $3.47M
Sga Expense Q3 2025 · Sep 30, 2024 $847.82K
Sga Expense Q3 2025 · Sep 30, 2024 $2.58M
Net Income Q3 2025 · Sep 30, 2025 −$537.92K
Net Income Q3 2025 · Sep 30, 2025 −$1.93M
Net Income Q3 2025 · Jun 30, 2025 −$649.69K
Net Income Q3 2025 · Mar 31, 2025 −$746.13K
Net Income Q3 2025 · Sep 30, 2024 −$578.17K
Net Income Q3 2025 · Sep 30, 2024 −$1.83M
Net Income Q3 2025 · Jun 30, 2024 −$540.09K
Net Income Q3 2025 · Mar 31, 2024 −$708.78K
Operating Income Q3 2025 · Sep 30, 2025 −$540.14K
Operating Income Q3 2025 · Sep 30, 2025 −$1.94M
Operating Income Q3 2025 · Sep 30, 2024 −$577.37K
Operating Income Q3 2025 · Sep 30, 2024 −$1.83M
Gross Profit Q3 2025 · Sep 30, 2025 $625.38K
Gross Profit Q3 2025 · Sep 30, 2025 $1.53M
Gross Profit Q3 2025 · Sep 30, 2024 $270.45K
Gross Profit Q3 2025 · Sep 30, 2024 $753.87K
Stock Issued Q3 2025 · Jul 30, 2025 527.61K sh